BionX Medical Technologies Inc, headquartered in Bedford, Mass, announces in a media release that it has entered an exclusive distribution agreement with Ottobock HealthCare GmbH, US headquartered in Austin, Tex, to distribute the BiOM prosthetic ankle in select European markets.
The markets will include Germany, Austria, Switzerland, and Scandinavia.
According to the release, the BiOM mechanotronic prosthetic ankle is engineered with powered propulsion.
“We are very pleased about our partnership with this innovative company,” says Dr Helmut Pfuhl, head of the Prosthetics Business Unit at Ottobock, in the release. He emphasizes that both companies share similar values and have entered into a partnership built upon strong collaboration.
“We are very excited about our partnership with Ottobock, a pioneer and market leader in orthotics and prosthetics,” states Charles Carignan, MD, President & CEO of BionX Medical Technologies Inc, in the release.
“This partnership will further expand our ability to offer normalized limb function and improved quality of life to enable more people around the world to realize their full potential,” he adds.
For more information, visit BionX Medical Technologies Inc.
[Source(s): BionX Medical Technologies Inc, Business Wire]